✦ LIBER ✦

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study

✍ Scribed by J.Anthony Gomes; John Ip; Francesco Santoni-Rugiu; Davendra Mehta; Arisan Ergin; Steven Lansman; Elena Pe; Teri Takle Newhouse; Sally Chao

Book ID: 119550677
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 156 KB
Volume: 34
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(99)00213-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Local Perivascular Delivery of Basic Fib

Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery : Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial

✍ Laham, R. J.; Sellke, F. W.; Edelman, E. R.; Pearlman, J. D.; Ware, J. A.; Brown 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 473 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB

A multicentre, randomized, double-blind

A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial

✍ Olivier F. Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence 📂 Article 📅 2009 🏛 Pulsus Group Inc 🌐 English ⚖ 803 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease

✍ Shmuel Fuchs; Nabil Dib; Barry M. Cohen; Petros Okubagzi; Edward B. Diethrich; A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## Background: The experience with direct myocardial injection of adenovirus encoding angiogenic growth factor is limited to invasive surgical approach. Accordingly, we sought to evaluate, for the first time, in a randomized, double‐blind, placebo‐controlled, phase I pilot study the sa